Avidity Partners Management LP / AXSM
Avidity Partners Management LP’s Axsome Therapeutics Inc. Position
Does Avidity Partners Management LP own Axsome Therapeutics Inc. (AXSM)? Not currently — the last reported position was 94.5K shares worth $10M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$10M
Q2 2025
Shares
94.5K
% of Portfolio
+1.97%
Quarters Held
16
position exited
Position History AXSM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 94.5K | $10M | +1.97% |
| Q1 2025 | 77.0K | $9M | +1.71% |
| Q4 2024 | 188.0K | $16M | +1.56% |
| Q3 2024 | 296.1K | $27M | +1.36% |
| Q2 2024 | 376.0K | $30M | +1.29% |
| Q1 2024 | 431.0K | $34M | +1.11% |
| Q4 2023 | 459.4K | $37M | +1.33% |
| Q3 2023 | 296.8K | $21M | +0.84% |
| Q2 2023 | 545.0K | $39M | +1.37% |
| Q1 2023 | 619.2K | $38M | +1.27% |
| Q4 2022 | 670.0K | $52M | +1.12% |
| Q3 2022 | 1.54M | $69M | +1.40% |
| Q1 2022 | 711.0K | $29M | +0.61% |
| Q4 2021 | 775.0K | $29M | +0.62% |
| Q3 2020 | 118.0K | $8M | +0.39% |
| Q2 2020 | 404.9K | $33M | +2.14% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Avidity Partners Management LP’s full portfolio or all institutional holders of AXSM.